Cuerpo Académico 454 Alimentación y Nutrición en el proceso Salud-Enfermedad, Laboratorio de Evaluación del Estado Nutricio, Departamento de Clínicas de la Reproducción Humana, Crecimiento y Desarrollo Infantil, División de Disciplinas Clínicas, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Calle Hospital 320, first floor (Antigua Escuela de Medicina, Universidad de Guadalajara), 44280 Guadalajara, Jalisco, México.
Public Health Nutr. 2011 Oct;14(10):1702-13. doi: 10.1017/S1368980010003320. Epub 2011 Apr 13.
To assess the available data on the prevalence of metabolic syndrome (MS) in Latin-American countries.
Systematic review. Searches were carried out in PubMed, ISIWeb, SCielo and Redalyc, using 'metabolic syndrome x' and 'prevalence' as keywords for titles and/or abstracts. Articles selected were cross-sectional studies in Latin-American countries, whose main objective was to study MS and whose study population is described below. MS must be determined using Adult Treatment Panel III criteria. Twelve studies with these criteria were selected, one of which was multi-centric.
Latin America.
Apparently healthy subjects aged 18-65 years (including young adult, mature adult and elderly populations) of both genders.
The general prevalence (weighted mean) of MS in Latin-American countries was 24·9 (range: 18·8-43·3) %. MS was slightly more frequent in women (25·3 %) than in men (23·2 %), and the age group with the highest prevalence of MS consisted of those over 50 years of age. The most frequent components of MS were low HDL cholesterol levels (62·9 %) and abdominal obesity (45·8 %). Similar outcomes were obtained from the multi-centre study on Latin-American populations analysed.
The present review brings us closer to an understanding of the prevalence of MS in Latin-American countries. However, it is not possible to know the full scope of the problem, partly because data from some countries are not available, and because the methodological differences among the studies published up to the present limit a joint analysis of their results.
评估拉丁美洲国家代谢综合征（MS）患病率的现有数据。
系统评价。在 PubMed、ISIWeb、SCielo 和 Redalyc 中使用“代谢综合征 x”和“患病率”作为标题和/或摘要的关键字进行搜索。选择的文章为拉丁美洲国家的横断面研究，其主要目标是研究 MS，且其研究人群如下所述。MS 必须使用成人治疗小组 III 标准进行确定。选择了符合这些标准的 12 项研究，其中一项为多中心研究。
拉丁美洲。
18-65 岁的健康成年人（包括青年、成年和老年人群），无论性别。
拉丁美洲国家 MS 的总体患病率（加权平均值）为 24.9%（范围：18.8-43.3）%。MS 在女性（25.3%）中略高于男性（23.2%），MS 患病率最高的年龄组为 50 岁以上人群。MS 最常见的表现为低 HDL 胆固醇水平（62.9%）和腹部肥胖（45.8%）。对分析的拉丁美洲人群多中心研究也得到了类似的结果。
本综述使我们更深入地了解拉丁美洲国家 MS 的患病率。然而，由于一些国家的数据不可用，以及迄今为止发表的研究之间的方法学差异限制了对其结果的联合分析，因此无法了解该问题的全貌。
